Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5Gynecologic 2Thoracic 1Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Neoplasm Metastasis 26Neoplasms 5

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × Specimen Handling × Tumor-Agnostic × Clear all
NCT06962995 2026-04-06

Multi-Cancer Detection Observational Cohort Study

Mayo Clinic

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT07131007 2026-03-23

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

Hebei Medical University Fourth Hospital

Recruiting
2,000 enrolled
Tumor-Agnostic

Neoplasms

NCT05746169 2025-12-30

Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

University of California, San Francisco

Terminated
1,576 enrolled
Tumor-Agnostic

Neoplasms

NCT06207864 2025-11-13

PE-CGS

New Mexico Cancer Research Alliance

Phase NA Recruiting
1,001 enrolled
Tumor-Agnostic

Neoplasms

NCT06832150 2025-02-18

SMS2

The Wellcome Sanger Institute

Enrolling by invitation
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡